IGBP1P2

Across TCGA pan-cancer cohorts, IGBP1P2 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated IGBP1P2 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGBP1P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated IGBP1P2 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CHOL show a favorable association.

HNSC, THYM, and CHOL are the cancer types where IGBP1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	IV	0.522	0.335	.005	58	view →
THYM	OS	Tertile	All	0.892	1.000	.003	37	view →
CHOL	OS	Tertile	All	1.000	0.498	.027	24	view →
MESO	DFS	Tertile	IV	0.163	0.379	.026	21	view →
LUSC	OS	Quartile	II,III,IV	0.189	0.463	<.001	21	view →
KIRP	DFS	Quartile	II,III,IV	0.858	0.594	.027	19	view →
KIRC	DFS	Quartile	II,III,IV	0.715	0.508	.017	18	view →
STAD	OS	Quartile	II,III,IV	0.501	0.752	.019	12	view →
READ	DFS	Tertile	All	0.707	0.889	.026	10	view →
LUAD	DFS	Median	III,IV	0.417	0.210	.011	10	view →
DLBC	OS	Tertile	All	0.643	0.941	.047	9	view →
THCA	DFS	Tertile	II,III,IV	0.264	0.812	.023	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

IGBP1P2–HNSC (OS)

Open the HNSC breakdown →